Icon of the Instituts for Quality and Efficiency in Health Care

Dossier assessment

Trifluridine/tipiracil (gastric cancer) - Benefit assessment according to §35a Social Code Book V

Status
Status: Commission completed
Project no.
A19-85
Last updated

Report documents

  1. Extract of dossier assessment

    Trifluridine/tipiracil (gastric cancer) - Benefit assessment according to §35a Social Code Book V

    published on
    Document type
    PDF document, 108 kB, DE, not accessible
    Download file : Extract of dossier assessment (PDF document, 108 kB, DE, not accessible)

  2. Dossier assessment

    Trifluridine/tipiracil (gastric cancer) - Benefit assessment according to §35a Social Code Book V

    published on
    Document type
    PDF document, 892 kB, DE, not accessible
    Download file : Dossier assessment (PDF document, 892 kB, DE, not accessible)

Dossier assessment

Indication:

Adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least 2 prior systemic treatment regimens for advanced disease

Result of dossier assessment:

Hint of considerable added benefit

Project details

Project no.
A19-85
Commission
Commission awarded on 02.10.2019 by the Federal Joint Committee (GBA).
Report type
Dossier assessment
Status
Commission completed
Department/Division
Drug Assessment
Topic
Cancer
Note

The current version 1.1 of the dossier assessment replaces version 1.0 published on 2020-01-15.


After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.

Connected Projects

  1. Dossier assessment

    Trifluridine/tipiracil (colorectal cancer) - Benefit assessment according to §35a Social Code Book V (expiry of the decision)

    Project no.
    A20-35
    Last updated

    Status: Commission completed

  2. Dossier assessment

    Trifluridine/tipiracil (colorectal cancer) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A16-54
    Last updated

    Status: Commission completed

  3. Addendum

    Trifluridine/tipiracil (colorectal cancer) - Addendum to Commission A16-54

    Project no.
    A16-77
    Last updated

    Status: Commission completed

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page